Home hover Guidelines hover Expert hover Compare hover Faq hover Submit hover About hover Resources hover Syntheses hover Myngc hover Guidelinematrix hover
Home
Browse Guidelines
Expert Commentaries
Guideline Syntheses
Guideline Matrix
Guideline Resources
Compare Guidelines
Frequently Asked Questions
Submit Guidelines
About
myNGC
< Back

'(bone' and 'metastasis)' and '(renal' and 'cell' and 'carcinoma)'
Run an advanced search on this term

Search within:  

Sort results by:      



Filter results by:

1-20 of 20  
 
1.  
Zoledronic acid for the treatment of bone metastases secondary to renal cell carcinoma. 2010 Jun 16. NGC:008092
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
2.  
ACR Appropriateness Criteria® renal cell carcinoma staging. 1995 (revised 2011). NGC:008871
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
3.  
ACR Appropriateness Criteria® single brain metastasis. 1999 (revised 2012). NGC:009678
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
4.  
5.  
Renal cell carcinoma. 2011 Jan (revised 2012 May). NGC:009081
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
6.  
ACR Appropriateness Criteria® metastatic bone disease. 1995 (revised 2012). NGC:009235
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
7.  
ACR Appropriateness Criteria® spinal bone metastases. 1996 (revised 2012). NGC:009677
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
8.  
ACR Appropriateness Criteria® pretreatment staging of invasive bladder cancer. 1995 (revised 2012). NGC:009670
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
9.  
ACR Appropriateness Criteria® pre-irradiation evaluation and management of brain metastases. 1999 (revised 2014). NGC:010462
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
10.  
ACR Appropriateness Criteria® screening for pulmonary metastases. 1995 (revised 2013). NGC:010164
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
11.  
Brain metastases. 2006 Jul (revised 2011). NGC:008770
European Academy of Neurology - Medical Specialty Society. View all guidelines by the developer(s)
13.  
ACR Appropriateness Criteria® post-treatment follow-up of renal cell carcinoma. 1996 (revised 2013). NGC:010165
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
14.  
Muscle invasive and locally advanced/metastatic bladder cancer. 2011 Jan (revised 2013 Oct). NGC:010249
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
15.  
Follow-up for clinically localized renal neoplasms: AUA guideline. 2013 Apr. NGC:009917
American Urological Association Education and Research, Inc. - Medical Specialty Society. View all guidelines by the developer(s)
16.  
ACR Appropriateness Criteria® non-invasive clinical staging of bronchogenic carcinoma. 1995 (revised 2013). NGC:010163
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
17.  
ACR Appropriateness Criteria® thyroid carcinoma. 2013. NGC:010177
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
18.  
ACR Appropriateness Criteria® staging of testicular malignancy. 1996 (revised 2012). NGC:009247
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
19.  
ACR Appropriateness Criteria® post-treatment surveillance of bladder cancer. 1996 (revised 2014). NGC:010458
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
20.  
1-20 of 20